Bedel Financial Consulting, Inc. Medtronic PLC Transaction History

Bedel Financial Consulting, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$87.4 - $113.09 $97,800 - $126,547	-1,119 Closed	0 $0
Q1 2022 Apr 19, 2022	SELL	$100.58 - $112.38 $13,678 - $15,283	-136 Reduced 10.84%	1,119 $124,000
Q4 2021 Jan 11, 2022	SELL	$99.53 - $127.75 $6,469 - $8,303	-65 Reduced 4.92%	1,255 $130,000
Q2 2021 Aug 03, 2021	BUY	$118.19 - $131.5 $21,274 - $23,670	180 Added 15.79%	1,320 $164,000
Q1 2021 Apr 26, 2021	BUY	$111.18 - $119.74 $2,334 - $2,514	21 Added 1.88%	1,140 $135,000

Q2 2020 Jul 14, 2020	SELL	$84.11 - $103.33 $78,474 - $96,406	-933 Reduced 45.47%	1,119 $103,000
Q1 2020 May 06, 2020	BUY	$72.92 - $121.3 $1,604 - $2,668	22 Added 1.08%	2,052 $185,000
Q3 2019 Oct 09, 2019	BUY	$98.02 - $111.18 $5,195 - $5,892	53 Added 2.68%	2,030 $220,000
Q3 2018 Nov 01, 2018	SELL	$85.91 - $99.17 $34,879 - $40,263	-406 Reduced 17.04%	1,977 $190,000
Q2 2018 Jul 18, 2018	SELL	$77.48 - $87.83 $1,317 - $1,493	-17 Reduced 0.71%	2,383 $204,000
Q1 2018 May 03, 2018	BUY	$76.55 - $87.26 $183,720 - $209,424	2,400 New	2,400 $193,000

2,237

1.05B

6.1M

7.84M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $103B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Bedel Financial Consulting, Inc., based on Form 13F filings with the SEC.

Stay updated on Bedel Financial Consulting, Inc. with notifications on news.